en

PRODUCT DETAIL

Tranexamic acid Kabi 10 mg/ml

Code 6069E
MA number 16/0085/24-S
Product Form: sol inf 20x50 ml/500 mg (fľ.PE (KabiPac))
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS
B02AA Amino acids
B02AA02 Tranexamic acid
Shelf life: 30
Container: bottle PE
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 25.04.2024
Validity: 25.04.2029
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_Tranexamic acid Kabi 10 mg_ml_04_2024.pdf  
SPC: SPC_Tranexamic acid Kabi 10 mg_ml_04_2024.pdf  
Safety feature Yes
Data update: 02.05.2024
eu-flag.png sk-flag.png